2xmc

G117H mutant of human butyrylcholinesterase in complex with fluoride anion

spinqualitylabelsall models 2xmc, resolution 2.40Å Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D Structural highlights 2xmc is a 1 chain structure with sequence from Human. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance. Ligands: CL, F, K, NAG, SO4, UNX, FUC Related: 2wsl, 2j4c, 2wik, 1kcj, 1p0p, 1xlu, 2wij, 1xlv, 1eho, 1p0m, 1xlw, 1ehq, 1p0q, 2wid, 2wil, 2wif, 1p0i, 2wig, 2xmd, 2xmb, 2xmg Activity: Cholinesterase, with EC number 3.1.1.8 Resources: FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT Disease [CHLE_HUMAN] Defects in BCHE are the cause of butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400]. BChE deficiency is a metabolic disorder characterized by prolonged apnoea after the use of certain anesthetic drugs, including the muscle relaxants succinylcholine or mivacurium and other ester local anesthetics. The duration of the prolonged apnoea varies significantly depending on the extent of the enzyme deficiency. BChE deficiency is a multifactorial disorder. The hereditary condition is transmitted as an autosomal recessive trait. Function [CHLE_HUMAN] Esterase with broad substrate specificity. Contributes to the inactivation of the neurotransmitter acetylcholine. Can degrade neurotoxic organophosphate esters. Publication Abstract from PubMed Organophosphylates (OPs) exert their acute toxicity through inhibition of acetylcholinesterase, by phosphylation of the catalytic serine. Engineering of human butyrylcholinesterase by substitution of histidine for glycine at position 117 led to the creation of OP hydrolase activity. But the lack of structural information and poor understanding of the hydrolytic mechanism of G117H has hampered further improvements in the catalytic activity. We solved the crystallographic structure of the G117H mutant with a variety of ligands in the active site. A sulfate anion bound to the active site suggested the positioning for an OP prior to phosphylation. A fluoride anion was found in the active site when NaF was added to the crystallization buffer. In the fluoride complex, the imidazole ring from His117 was substantially shifted adopting a relaxed conformation most likely close to that of the unliganded mutant enzyme. Additional X-ray structures were obtained from the transient covalent adducts formed upon reaction of G117H with the OPs echothiophate and VX. The position of His117 shifted in response to the introduction of these adducts, overlaying the phosphylserine. These structural data suggest that the dephosphylation mechanism involves either a substantial conformational change of His117 or an adjacent nucleophilic substitution by water. X-ray crystallographic snapshots of reaction intermediates in the G117H mutant of human butyrylcholinesterase, a nerve agent target engineered into a catalytic bioscavenger.,Nachon F, Carletti E, Wandhammer M, Nicolet Y, Schopfer LM, Masson P, Lockridge O Biochem J. 2010 Nov 19. PMID:21091433 From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See Also Butyrylcholinesterase 3D structures

Proteopedia Page Contributors and Editors (what is this?)

OCA